Please login to the form below

Not currently logged in
Email:
Password:

Warner Chilcott

This page shows the latest Warner Chilcott news and features for those working in and with pharma, biotech and healthcare.

US tax changes claim Pfizer scalp as Allergan deal abandoned

US tax changes claim Pfizer scalp as Allergan deal abandoned

So for Allergan - formerly known as Actavis, its acquisitions of Warner Chilcott in 2013, Forest Laboratories in 2014 and Allergan in 2015 that turned it into a $109bn company would be

Latest news

More from news
Approximately 3 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Pharma deals during September 2014 Pharma deals during September 2014

    Virgin Media. UK. 2013. Actavis. Warner Chilcott. Ireland. 2013. Perrigo. Elan.

  • Pharma deals during April 2014 Pharma deals during April 2014

    This is the latest of the Actavis buying binge frenzy adding to the acquisition of Warner Chilcott last year and Forest Laboratories last month.

  • Pharma deals during March 2014 Pharma deals during March 2014

    This follows on from several other acquisitions of Irish entities, which result in US companies paying Irish corporation tax, eg the acquisition by Perrigo of Elan and Actavis' acquisition of Warner ... Chilcott last year.

  • Pharma deals during February 2014 Pharma deals during February 2014

    This deal comes hot on the heels of the acquisition of Warner Chilcott in 2013 and Watson Pharmaceuticals' acquisition of Actavis back in 2012.

  • Deal Watch table for May 2013 Deal Watch table for May 2013

    Bausch &Lomb/ Valeant. Company acquisition. Ophthalmology business. 8, 700. Warner Chilcott/ Actavis.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics